Skip to main content

Table 1 Overall prevalence of HPV genotype in single and multiple infections

From: Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012–2018: baseline measures prior to mass HPV vaccination

Genotypes Single infection Multiple infections Total
(n, %) 95% CI (n, %) 95% CI (n, %) 95% CI
HR-HPV*
 52 7457(3.47) 3.39–3.55 3537(1.65) 1.60–1.70 10,994 (5.12) 5.03–5.21
 16 4183 (1.95) 1.89–2.01 2175 (1.01) 0.97–1.05 6358 (2.96) 2.89–3.03
 58 3267 (1.52) 1.47–1.57 2128 (0.99) 0.95–1.03 5395 (2.51) 2.44–2.58
 53 2261 (1.05) 1.01–1.09 1683 (0.78) 0.74–0.82 3944 (1.84) 1.78–1.90
 39 1747 (0.81) 0.77–0.85 1330 (0.62) 0.59–0.65 3077 (1.43) 1.38–1.48
 51 1284 (0.60) 0.57–0.63 1030 (0.48) 0.45–0.51 2314 (1.08) 1.04–1.12
 68 1187 (0.55) 0.52–0.58 1092 (0.51) 0.48–0.54 2279 (1.06) 1.02–1.10
 33 1231 (0.57) 0.54–0.60 1031 (0.48) 0.45–0.51 2262 (1.05) 1.01–1.09
 18 1279 (0.60) 0.57–0.63 878 (0.41) 0.38–0.44 2157 (1.00) 0.96–1.04
 31 841 (0.39) 0.36–0.42 664 (0.31) 0.29–0.33 1505 (0.70) 0.67–0.74
 66 598 (0.28) 0.26–0.30 639 (0.30) 0.28–0.32 1237 (0.58) 0.55–0.61
 56 501 (0.23) 0.21–0.25 520 (0.24) 0.22–0.26 1021 (0.48) 0.45–0.51
 59 436 (0.20) 0.18–0.22 368 (0.17) 0.15–0.19 804 (0.37) 0.35–0.40
 45 225 (0.10) 0.09–0.11 258 (0.10) 0.11–0.14 483 (0.22) 0.20–0.24
 35 258 (0.12) 0.11–0.14 200 (0.09) 0.08–0.10 458 (0.21) 0.19–0.23
LR- HPV#
 81 2240 (1.04) 1.00–1.08 1743 (0.81) 0.77–0.85 3983 (1.86) 1.80–1.92
 6 765 (0.36) 0.34–0.39 723 (0.34) 0.32–0.37 1488 (0.69) 0.66–0.73
 11 643 (0.30) 0.28–0.32 519 (0.24) 0.22–0.26 1162 (0.54) 0.51–0.57
 44 380 (0.18) 0.16–0.20 342 (0.16) 0.14–0.18 722 (0.34) 0.32–0.37
 42 173 (0.08) 0.07–0.09 148 (0.07) 0.06–0.08 321 (0.15) 0.13–0.17
 43 92 (0.04) 0.03–0.05 105 (0.05) 0.04–0.06 197 (0.09) 0.08–0.10
Total 31,048 (14.46) 14.31–14.61 9120 (4.25) 4.17–4.34 40,168 (18.71) 18.55–18.88
  1. Single infection versus multiple infections considering HR-HPV *P < 0.001 and LR- HPV #P < 0.001. HPV Human papillomavirus, HR-HPV High-risk HPV, LR-HPV Low-risk HPV, CI Confidence interval